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Objective: Diagnostic rates of unknown primary head and neck carcinoma (UPHNC)
using lingual tonsillectomy (LT) are highly variable. This study sought to determine the
diagnostic value of LT in UPHNC identification using strict inclusion criteria and definitions
to produce a more accurate estimate of diagnosis rate.
Methods: In this retrospective chart review, records of patients who underwent LT for
UPHNC were reviewed. Inclusion criteria included absence of suspicious findings on
physical exam and positron emission tomography-computed tomography as well as
negative biopsies after panendoscopy and palatine tonsillectomy. Following inclusion
criteria, 16 patients were reviewed. A systematic literature review on LT for the workup
of CUP was also performed.
results: LT was performed using transoral robotic surgery (TORS), transoral laser
microsurgery (TLM), or transoral microsurgery with cautery (TMC). Following LT, primary
tumor was identified in 4 patients out of 16. Detection rate by technique was 1/6, 2/7,
and 1/3 for TORS, TLM, and TMC respectively. Postoperative bleeding occurred in three
patients (19%); however, this was not related to the LT. Following literature review, 12
studies were identified; however, only 3 had enough data to compare against. All three
studies had a cohort with suspicious findings on clinical exam. A total of 34 patients
had a negative workup, with no suspicious findings on clinical exam and subsequently
received an LT.
conclusion: This study suggests that LT should be considered initially in the diagnostic
algorithm for UPHNC. This study can increase the patient size in this cohort by approximately 47%.
Keywords: squamous cell carcinoma, unknown primary, lingual tonsillectomy, transoral robotic surgery, transoral
laser microsurgery
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SUMMARY

in preoperative assessment, imaging, and surgical technique. We
hypothesize that, with adherence to strict inclusion criteria for
unknown primary based on negative clinical evaluation as well
as PET-CT imaging without any suggestion of primary location,
LT would result in a lower UPHNC detection rate than what is
reported in most of the existing literature. In addition, we have
performed a systematic review of literature to compare our results
with similar studies.

• The rate of unknown primary detection from LT in the literature ranges from 18 to 90%, a range which may stem from
small cohorts and heterogeneity of inclusion criteria.
• The rate of unknown primary detection from LT in this study
was 25%.
• Bleeding was the most common complication and occurred in
19% of cases.
• LT should be advocated in the diagnostic algorithm for
UPHNC to improve early detection rates.

MATERIALS AND METHODS
Approval for this study was obtained through the DartmouthHitchcock Institutional Review Board. We reviewed the medical
records of all patients presenting between February 2010 and May
2017 who had undergone LT and biopsy-proven metastatic SCC
to cervical lymph nodes without an identified primary site. The
patients were first evaluated in the outpatient setting and had
negative findings on physical exam, flexible laryngoscopy, and
PET-CT. To fit our inclusion criteria for unknown primary based
on PET-CT, the imaging study had to be entirely negative without any suggestion of a primary site. Further inclusion criteria
required patients to have undergone LT in addition to standard
staging laryngoscopy/palatine tonsillectomy as part of their
diagnostic workup. LT could have been performed concurrently
with standard staging laryngoscopy/palatine tonsillectomy, or as
a second procedure.
For all three approaches, the LT is performed by first making
an incision along the lateral base of tongue and then carefully
dissecting the lingual tonsillar tissue off the fold and tongue musculature. Dissection is carried down to the vallecula, the midline
of the tongue base, and up to the circumvallate papillae and foramen cecum. The specimen is removed en bloc. The lingual tonsils
are removed separately. After the tonsillar tissue is oriented with a
suture, it is submitted for permanent pathologic analysis.
For TORS procedures, the da Vinci S or da Vinci Xi system is
utilized. Exposure of the lingual tonsil is achieved by retracting
the oral tongue forward and placing a Crowe–Davis retractor. A
30° 12 mm (da Vinci S) or 8 mm (da Vinci Xi) telescope, a combination of Maryland and Schertel graspers, and Bovie cautery
attachments are utilized.
For TLM and transoral microsurgery with cautery (TMC)
procedures, exposure is similar utilizing either the Lindholm
operating laryngoscope or by retracting the tongue forward and
placing a Crowe–Davis retractor. Visualization is achieved with
an operating microscope (TLM and TMC) or laryngeal telescope
(TMC). For TLM, a CO2 laser attached to a micromanipulator on
the microscope is used whereas for TMC, a bovie cautery with an
extended spatula tip is used.

INTRODUCTION
Unknown primary head and neck carcinoma (UPHNC) presents
as metastatic malignancy identified in a cervical lymph node without identification of primary origin on diagnostic examination
(1, 2). When pathology is consistent with p16 positive squamous
cell carcinoma (SCC), the oropharynx is the most likely source of
origin (3, 4). Representing approximately 2–5% of all new head
and neck malignancies, the primary site is eventually isolated to
the palatine or lingual tonsils in 80–90% of patients (5, 6). When
encountered, the first step in the work up of UPHNC is clinical
evaluation involving a full history and physical exam, including
flexible fiber optic laryngoscopy. Positron emission tomographycomputed tomography (PET-CT) is often performed and carries
a diagnostic rate of 7–38% (7, 8). Once imaging is complete,
panendoscopy with tumor mapping is performed, with or without
palatine tonsillectomy. Reported diagnostic rates of tumor mapping are approximately 20–50% when biopsies can be targeted
with PET-CT; however, diagnostic rates markedly decrease to
9–29% when PET-CT is negative (5, 6, 9, 10).
The treatment of UPHNC entails neck dissection plus chemoradiation (CRT), neck dissection plus radiation, primary CRT,
or primary radiation. Because a primary site cannot be identified, radiation fields are broad to target the entire oropharynx
and hypopharynx, increasing risk of developing dysphagia,
odynophagia, xerostomia, and dysphonia (1). Some studies have
also suggested decreased survival in patients treated for UPHNC
(11). When tumor location can be identified, radiotherapy can be
targeted and intensity modulated to reduce side effects while still
providing adequate treatment doses (12, 13).
The importance of reducing morbidity through primary site
identification has spurred investigations into diagnostic protocol
improvement. The addition of lingual tonsillectomy (LT) has
become an increasingly prevalent adjunct due to improved diagnostic rates and low morbidity. In recent years, these procedures
have been performed using transoral laser microsurgery (TLM)
and transoral robotic surgery (TORS) as they enhance both visualization and mobility of tissue compared with traditional transoral instruments (14). With the addition of palatine and/or LT,
primary site detection rates have been reported as high as 94% in
addition to providing 100% 5-year disease free survival rates (15).
With TORS, LT alone has reported diagnostic rates of 18–90%
(1, 14, 16–19). This broad variation in diagnostic rates is likely
due to the relative infrequency of UPHNC; studies assessing the
diagnostic utility of LT contain small cohorts as well as differences
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Search Strategy

A systematic review of published reports on LT for the workup of
CUP was performed from June 2015 to March 2018 on MEDLINE,
Cochrane Central Register, and CINAHL for all relevant Englishlanguage studies. Before June 2015, a systematic review from Fu
et al. (19) was used. Keywords and subject headings specifying
unknown primary, LT, SCC, and TORS or TLM were used to
identify studies. Studies that included less than five patients were
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excluded. These studies also had to provide data on the number of
patients who did not have suspicious findings on clinical workup
and subsequently had an LT.

All FNA/core biopsies of the metastatic nodes identified SCC,
75% of which were p16 positive (Table 2). All patients underwent
preoperative PET-CT, none of which showed evidence of primary
tumor localization.

RESULTS AND ANALYSIS

Surgical Approach

Between February 2010 and May 2017, 16 patients met inclusion criteria and underwent TORS, TLM, or TMC LT. Of the 16
patients, 13 were male (81%). The ages ranged from 42 to 71, with
a mean age of 59. Nine of the patients used tobacco and six of the
patients reported daily alcohol use. One patient had a history of
both basal cell carcinoma on his scalp and prostate cancer with no
evidence of disease since prostatectomy in 2011. The remaining
patients denied any previous malignancy. Demographic details of
these patients are depicted in Table 1.

Lingual tonsillectomy was performed either during the standard staging laryngoscopy (7/16) or as a secondary procedure
(9/16) with 8 patients receiving bilateral LT. Unilateral LT was
performed in patients undergoing concurrent palatine tonsillectomy and was intended to minimize the small theoretical risk of
oropharyngeal stenosis resulting from circumferential denuding
of mucosa (20). Seven patients had their palatine tonsils removed
for unrelated reasons before their current presentation. LT was
performed using TORS (6/16), TLM (7/16), or TMC (3/16) with
a detection rate of 25% (4/16). All detectable carcinomas were
found on the ipsilateral side of the presenting lymph node. Of
the four detectable carcinomas, one was 0.5 cm × 0.4 cm in size,
a second was 0.3 cm in its largest diameter, a third was too small
for measurement but had a small focus of cancerous cells, and the
fourth extended into the deep margin with a surface epithelial to

Clinical Workup

Fifteen patients presented with a level II and/or level III cervical node, and one patient presented with a level I lymph node.
There were no localizing ENT symptoms, and all patients had
negative findings on physical exam and flexible laryngoscopy.
Table 1 | Patient demographics and comorbidities.
Age (years)
Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
Case 7
Case 8
Case 9
Case 10
Case 11

56–60
56–60
56–60
61–65
66–70
41–45
66–70
56–60
51–55
46–50
51–55

Tobacco abuse

Tobacco abuse

EtOH abuse

Comorbidities

40 packs/year
None
None
40 packs/year
40 packs/year
25 packs/year
None
None
10 packs/year
None
20 packs/year

40 packs/year
None
None
40 packs/year
40 packs/year
25 packs/year
None
None
10 packs/year
None
20 packs/year

6 drinks/day
None
None
None
None
None
2 drinks/day
None
None
None
1 drink/day

None
None
None
T2DM, prostate CA, HTN, obesity
Stroke, CAD, HTN, HLD, atrial flutter
Anxiety, depression
Hearing loss
None
None
HLD, asthma
T1DM, osteoarthritis

Table 2 | Patient nodal status, surgery, and results.
Nodal
status

Surgery

Lingual tonsil

Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
Case 7
Case 8
Case 9
Case 10
Case 11

R N2a
R N2
R N2
L N2
L N3
L N2
L N1B
R N2
R N2
R N2
R N2

Transoral laser microsurgery (TLM) CO2
TLM CO2b
TLM CO2
TLM CO2
TLM CO2b
TLM CO2
TLM CO2
Transoral robotic surgery (TORS)b
TORSb
Transoral microsurgery with cautery (TMC)
TMCb

Positive
Negative
Negative
Negative
Negative
Negative
Positive
Negative
Negative
Negative
Positive

Case 12
Case 13
Case 14
Case 15
Case 16

R N2
L N2
L N2
R N2
R N2

TORS
TORSb
TORS
TORSb
TMCb

Negative
Positive
Negative
Negative
Negative

Concurrent neck
dissection

Tumor size

Margins

p16

N
Y
N
Y
Nc
N
N
N
Y
Nc
Nc

0.5 cm × 0.4 cm
N/A
N/A
N/A
N/A
N/A
Small foci
N/A
N/A
N/A
Undetermined

Negative
Positive
Positive
Positive
Negative
Positive
Positive
Positive
Positive
Positive
Positive

Y
Y
Y
Y
N

N/A
0.3 cmd
N/A
N/A
N/A

Negative
N/A
N/A
N/A
N/A
N/A
Negative
N/A
N/A
N/A
Positive: deep
margin
N/A
Negative
N/A
N/A
N/A

Positive
Positive
Positive
Negative
Negative

Liver and axillary metastasis.
Bilateral lingual tonsillectomy.
c
Neck dissection as a second procedure.
d
In the largest diameter.
a

b
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deep margin measurement of 0.5 cm. Three of the four carcinomas were p16 positive (Table 2).

did not provide enough data on lingual tonsillectomies performed
after a completely negative workup and were excluded. On the
literature search from June 2015 to March 2018, four studies were
identified. Of the four papers, one was the systematic review from
Fu et al., and a second focused on radiotherapy characteristics
and outcomes, and the last two did not include enough data. After
review, three studies were included in our analysis.

Complications

Although three patients develop bleeding postoperatively, none
of the bleeding was associated with the LT. One patient required
reoperation for bleeding from the palatine tonsil on postoperative day (POD) 6. This patient took apixaban on POD 5 due to
a history of atrial flutter and stroke. A second patient had an
expanding hematoma after neck dissection immediately postop
and required operative management. A third patient presented
to the Emergency Department for a palatine tonsillar bleed on
POD 12, which was treated with topical silver nitrate cautery.
All 16 patients were able to tolerate a soft diet at the first postoperative visit, and no patients had any significant weight loss.
No patients required a G-tube following surgery. Three patients
noted taste disturbances following surgery that improved on
follow-up. There were no other complications from TORS, TLM,
or TMC LT.

DISCUSSION
Although not always possible, identification of the site of origin
for unknown primary SCC is an essential goal for the head and
neck surgeon. Radiotherapy increases patient morbidity with side
effects such as xerostomia, dysphagia, and odynophagia; when
treatments can be targeted to an identified location, patient morbidity is reduced. In addition, in select patients, treatment may
consist of resection alone with avoidance of radiation depending
on pathology and margin status. Thus, methods for increasing
primary site identification are of great interest.
While there is currently no universal guideline for workup
of unknown primary SCC of the head and neck, a national
guideline is present in the United Kingdom. Typically, a workup
starts with a full history and physical exam with flexible fiber
optic laryngoscopy. PET-CT is often incorporated and presents
a diagnostic rate ranging from 7 to 38% (7, 8). However, a major
limitation of PET-CT is that tumors less than 1 cm in diameter are not reliably detected (21). In a study of 111 identified
unknown primary tumors, the average diameter was 1.15 cm,
and 57% of tumors were less than 1 cm in diameter (19). These
data suggest that more than half of unknown primary tumors
may be below PET-CT detection level, and their reported value
may be an underestimation since tumors included were those
able to be identified with imaging or panendoscopy. Despite this,
Mackenzie et al. and the United Kingdom National Guidelines
recommend that all patients presenting with confirmed cervical
lymph node metastatic SCC and no identifiable primary should
undergo PET/CT (22).
Once imaging is complete, panendoscopy with tumor
mapping is traditionally performed. When PET-CT is able to
provide targeted biopsies, diagnostic rates of tumor mapping
range from 20 to 50% (5, 6, 9, 10). However, when physical
exam and PET-CT are negative, diagnostic rates decrease to a
range of 9–29% (5, 10). Depending on the institution, palatine
tonsillectomy may be performed during panendoscopy and has
been shown to provide cancer detection rates superior to biopsy
of tonsillar tissue alone (23).
In recent years, LT performed with TLM and TORS has shown
promising results at increasing UPHNC detection with rates ranging from 18 to 90%. The dramatic differences in detection rate are
likely secondary to small cohorts in all studies, a consequence of
infrequent presentation. We report an overall detection rate of
25% with LT. This detection rate is lower than most previously
reported studies, but this is most likely secondary to our strict
inclusion criteria. For the 16 patients in our study, there could be
absolutely no suspicious findings on physical exam or PET-CT,
and panendoscopic biopsies must all have been negative.
In a study by Mehta et al., LT with TORS yielded a 90%
detection rate; however, 40% of these had positive BOT PET-CT

Follow-Up

Follow-up ranged from 3.6 months to almost 7 years after LT with
an average follow-up of 3.5 years. Following LT, seven patients
received CRT, and four patients received only radiotherapy. Five
patients elected to clinically monitor their status without chemotherapy or radiotherapy. Fourteen patients on last follow-up are
alive without evidence of disease (Table 3). One patient developed
recurrence in the right neck at levels IV and V, with spread to the
liver and axilla 4 months after completion of radiotherapy. This
patient was 1 of 4 cases that had a p16-negative carcinoma. She
was a heavy smoker (40 pack/years) and heavy drinker (6 drinks/
day) who continued to smoke after diagnosis and surgery. The
final patient, in whom a primary cancer was never found, died
from acute myeloid leukemia, 3 years after his initial LT with no
evidence of recurrence of his UPHNC.
The systematic review from Fu et al. identified a total of eight
studies, three of which had less than five patients, and two studies
Table 3 | Postoperative care and follow-up.

Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
Case 7
Case 8
Case 9
Case 10
Case 11
Case 12
Case 13
Case 14
Case 15
Case 16

Adjuvant
therapy

Disease
status

RT
RT
CRT
CRT
None
CRT
CRT
CRT
CRT
None
RT
None
RT
None
None
CRT

AWD
NED
NED
NED
NED
NED
NED
DSD
NED
NED
NED
NED
NED
NED
NED
NED

Surgery to last follow-up
(months)
8.7
23.6
21.7
12.3
7.1
52.6
38.2
30.7
27.5
12.4
5.5
84.3
3.6
19.9
9.8
6.5

RT, radiation therapy; CRT, chemoradiation; AWD, alive with disease; NED, no evidence
of disease; DSD, died without disease.
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findings, 20% of which were positive in the BOT ipsilateral to
imaging, and 20% were positive on the contralateral BOT according to imaging (1). In a multi-institutional study by Patel et al.,
palatine and LT using TORS together resulted in 72.3% (34/47)
tumors identified (14). For LT alone, the isolation rate was 42.6%
(20/47). However, in this study 48.9% of patients had suspicious
physical exam findings, 56.5% of which were confirmed to be
cancer, and 34% of which had suspicious findings on PET-CT,
50.0% of which were confirmed to be malignancy. Nagel et al.
performed LT on 14 patients, 57% (8/14) of which were positive,
but it was not indicated whether imaging took place prior (17). It
is likely that these rates of successful diagnosis are higher than our
cohort secondary to inclusion of patients who had either suspicious exam findings or positive PET-CT findings, which would
both increase the likelihood of included tumors being larger in
size and thus easier to isolate.
However, a counterpoint would be that PET-CT carries a
false positive rate up to 37%, thus patients with positive PET-CT
findings could still be considered unknown primary (7).
Furthermore, in a study by Durmus et al., of the 22 patients who
underwent either a combination of palatine tonsillectomy with
LT, LT alone, radical tonsillectomy, or base of tongue resection
with TORS, lingual tonsils were positive in 4/22 (18%) of cases
(18). This study presents a detection rate lower than that of our
study, yet nine patients (40.9%) had PET-CT findings confirmed
by surgical resection. Granted, most of these were positive palatine tonsils.
Most recently, a systematic review by Fu et al. reported LT
identifying primary tumor in 72% (18/25) patients with no findings (19). The cohort size included in the systematic review was
limited by heterogeneity of preoperative workups, definitions
of unknown primary, and limited information regarding exact
surgical techniques utilized in the literature. A prospective, multiinstitutional trial utilizing homogenous preoperative workup,
imaging, and surgical techniques would be required to present
an accurate UPHNC diagnosis from LT.
In accordance with current changes in the epidemiological
landscape in oropharyngeal SCC, the majority of neoplasms
(75%) in this study were p16 positive (24). Although conclusions
cannot be drawn based on low sample size, the detection rate of

p16 positive tumors was higher than that of p16-negative tumors,
rates being 75 and 25%, respectively.
Despite a large range of tumor isolation reported from LT,
it is a useful adjunct in UPHNC identification and carries low
risk of morbidity. The most common adverse event from LT
is postoperative bleeding in 5% of cases (19). In this study,
although three patients had bleeding events after surgery, none
were related to the LT itself. Given that all reported LT UPHNC
diagnostic rates exceed this value, it may be reasonable to
perform LT at the time of panendoscopy with intent to save
the patient a separate surgery and potentially expedite diagnosis
and treatment.
The primary weakness of this study, one shared among all of
the existing literature, is a small patient cohort. The uncommon
presentation of unknown primary SCC in the head and neck in
addition to our strict criteria were some of the reasons explaining
the number of patients included in our study. After the literature
review, only three studies, namely, Mehta et al. (1), Patel et al.
(14), and Nagel et al. (17), provided enough information to
determine an identification rate for LT after a negative clinical
workup, including an absence of suspicious findings on PET-CT,
panendoscopy with biopsies, and palatine tonsillectomy. When
all suspicious findings were excluded, 43 cases from the three
studies remain, with 34 receiving LT (Table 4). Although a
small patient cohort is present, it is similar to other studies and
increases the number of patients with a negative clinical workup
and subsequent LT by almost 50%. Another potential weakness
of this study is that three differing resection techniques were
utilized, although successful identification of a primary was
achieved with each technique. Of note, seven patients had a neck
dissection concurrent with the tonsillectomy, three patients
had a neck dissection as a second procedure, and six elected to
not have a neck dissection. The differences in practice patterns
were largely a result of recommendations from tumor board,
dependent on the characteristics of the metastatic node and if
the patient elected to receive adjuvant therapy. Finally, in eight
patients, LT was only performed on the side of the presenting
nodal metastasis. While unilateral LTs were performed to reduce
patient morbidity, reported rates of unknown primary in the
contralateral lingual tonsil are 10% (18).

Table 4 | Proportion of patients without suspicious findings on diagnostic workup and identification in the lingual tonsil.
Reference

Institution

Proportion with
suspicious findings

Proportion without suspicious
findings on PET/CT, EUA with biopsy,
and palatine tonsillectomy

Identification in
lingual tonsil after
negative workup

Mehta et al. (1)

University of Pittsburgh Medical Center

4/10

6/10

5/6

Patel et al. (14)

University of Washington Medical Center

32/47

15/47

8/14

MD Anderson Cancer Center
University of Alabama Birmingham
University of Texas Medical School at Houston
Johns Hopkins Hospital
Oregon Health & Sciences University
Nagel et al. (17)

Mayo Clinic Arizona

30/52

22/52

8/14

Sudoko et al. (the
current study)

Dartmouth-Hitchcock Medical Center

0/16

16/16

4/16

Frontiers in Oncology | www.frontiersin.org

5

April 2018 | Volume 8 | Article 118

Sudoko et al.

Diagnostic Value of LT in UPHNC Identification

The rate of unknown primary detection from LT in patients
with a negative PET/CT was 25%. The rate of unknown primary
detection from LT in the literature ranges from 18 to 90%, although
cohort size is a limitation of all existing studies. Nevertheless, LT
improves unknown primary site identification and carries low risk
of complications and therefore should be advocated in the diagnostic algorithm for UPHNC to minimize treatment morbidity.
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